Literature DB >> 12513648

The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).

William S Stokes1, Leonard M Schechtman, Richard N Hill.   

Abstract

Over the last decade, national authorities in the USA and Europe have launched initiatives to validate new and improved toxicological test methods. In the USA, the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and its supporting National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) were established by the Federal Government to work with test developers and Federal agencies to facilitate the validation, review, and adoption of new scientifically sound test methods, including alternatives that can refine, reduce, and replace animal use. In Europe, the European Centre for the Validation of Alternative Methods (ECVAM) was established to conduct validation studies on alternative test methods. Despite differences in organisational structure and processes, both organisations seek to achieve the adoption and use of alternative test methods. Accordingly, both have adopted similar validation and regulatory acceptance criteria. Collaborations and processes have also evolved to facilitate the international adoption of new test methods recommended by ECVAM and ICCVAM. These collaborations involve the sharing of expertise and data for test-method workshops and independent scientific peer reviews, and the adoption of processes to expedite the consideration of test methods already reviewed by the other organisation. More recently, NICEATM and ECVAM initiated a joint international validation study on in vitro methods for assessing acute systemic toxicity. These collaborations are expected to contribute to accelerated international adoption of harmonised new test methods that will support improved public health and provide for reduced and more-humane use of laboratory animals.

Entities:  

Mesh:

Year:  2002        PMID: 12513648     DOI: 10.1177/026119290203002S04

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  6 in total

Review 1.  Collaborative healthcare research: some ethical considerations.

Authors:  Mohsin Raza
Journal:  Sci Eng Ethics       Date:  2005-04       Impact factor: 3.525

2.  The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.

Authors:  Michael Balls; Patric Amcoff; Susanne Bremer; Silvia Casati; Sandra Coecke; Richard Clothier; Robert Combes; Raffaella Corvi; Rodger Curren; Chantra Eskes; Julia Fentem; Laura Gribaldo; Marlies Halder; Thomas Hartung; Sebastian Hoffmann; Leonard Schectman; Laurie Scott; Horst Spielmann; William Stokes; Raymond Tice; Drew Wagner; Valérie Zuang
Journal:  Altern Lab Anim       Date:  2006-12       Impact factor: 1.303

3.  Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats.

Authors:  G J Coope; A M Atkinson; C Allott; D McKerrecher; C Johnstone; K G Pike; P C Holme; H Vertigan; D Gill; M P Coghlan; B Leighton
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

4.  Evaluation of Culture Time and Media in an In Vitro Testis Organ Culture System.

Authors:  Noriko Nakamura; Gwenn E Merry; Amy L Inselman; Daniel T Sloper; Pedro L Del Valle; Takuya Sato; Takehiko Ogawa; Deborah K Hansen
Journal:  Birth Defects Res       Date:  2017-03-31       Impact factor: 2.344

5.  Systematic Identification of Molecular Targets and Pathways Related to Human Organ Level Toxicity.

Authors:  Tuan Xu; Leihong Wu; Menghang Xia; Anton Simeonov; Ruili Huang
Journal:  Chem Res Toxicol       Date:  2020-11-29       Impact factor: 3.973

Review 6.  Reduction of Animal Sacrifice in Biomedical Science & Research through Alternative Design of Animal Experiments.

Authors:  Jagdish Rai; Kuldeep Kaushik
Journal:  Saudi Pharm J       Date:  2018-03-12       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.